The nucleolar proteins which link cell proliferation to ribosome biogenesis are regarded to be potentially oncogenic. Here, in order to examine the involvement of an evolutionary conserved nucleolar protein SURF6/Rrp14 in proliferation of mammalian cells, we established stably transfected mouse NIH/3T3 fibroblasts capable of conditional overexpression of the protein. Cell proliferation was monitored in real-time, and various cell cycle parameters were quantified based on flow cytometry, Br-dU-labeling and conventional microscopy data. We show that overexpression of SURF6 accelerates cell proliferation and promotes transition through all cell cycle phases. The most prominent SURF6 proproliferative effects include a significant reduction of the population doubling time, from 19.8±0.7 to 16.2±0.5 hours (t-test, p<0.001), and of the length of cell division cycle, from 17.6±0.6 to 14.0±0.4 hours (t-test, p<0.001). The later was due to the shortening of all cell cycle phases but the length of G1 period was reduced most, from 5.7 ±0.4 to 3.8 ±0.3 hours, or by ~30%, (t-test, p<0.05). By Northern blots and qRT-PCR, we further showed that the acceleration of cell proliferation was concomitant with an accumulation of rRNA species along both ribosomal subunit maturation pathways. It is evident, therefore, that like the yeast homologue Rrp14, mammalian SURF6 is involved in various steps of rRNA processing. We also concluded that SURF6 is a novel positive regulator of proliferation and G1/S transition in mammals, implicating that SURF6 is a potential oncogenic protein, which can be further studied as a putative target in anti-cancer therapy.
Introduction
Ribosome biogenesis is a complex, time-ordered and energy-consuming process that occurs mainly in the nucleolus. In nucleoli of mammalian cells, rRNA genes are transcribed to yield the primary 47S pre-rRNA transcripts, which then undergo numerous cleavage reactions, post-transcriptional modifications and interactions with appropriate proteins to provide a cell with the required number of 18S, 5.8S and 28S rRNAs and ribosomes. 1, 2 Ribosome synthesis is strictly coordinated with cell growth and proliferation, so that actively dividing cells, including tumor and embryo cells, have particularly well developed nucleoli. 3 In line with these data, in vitro experiments
showed that dysregulation of nucleolar proteins either leads to an arrest of cell cycle and drives cells to apoptosis or, in opposite, facilitates cell transformation and uncontrolled proliferation. 4, 5 Consequently, identification of the nucleolar proteins involved in cell cycle regulation is important not only for elucidating mechanisms which underlay the relationship between nucleolar functions and cell cycle control but also towards the development of novel therapeutic interventions for cancer treatment. [5] [6] [7] [8] [9] Several auxiliary rDNA transcription regulators and numerous rRNA processing factors such as endo-and exoribonucleases, RNA helicases, NTPases and methyltransferases are involved in the synthesis and maturation of rRNAs. 10, 11 Some of these factors are multifunctional proteins, which in addition to making ribosomes also participate to cell proliferation. Among the later are the abundant nucleolar chaperons NPM1 (B23/nucleophosmin) and nucleolin/C23 which promote cell proliferation through stimulatory effects on rDNA transcription, ribosome subunit export and DNA replication. 12, 13 Overexpression of the Bop1 protein, a member of the PeBoW complex that is essential for maturation of the large ribosomal subunit, impairs cell proliferation by increasing the percentage of abnormal multipolar mitotic figures. 14, 15 In addition, several nuclear and cytoplasmic proteins with a partial occurrence in nucleoli are also linked to proliferative processes. Such proteins include the nuclear proteins CHD7, 16 Las1L, 17 DHX33 helicase, 18 Sirt6, 19 PHF6, 20 and NSA2 21 as well as ribosomal proteins S3a 22 and L36a. 23 SURF6 has been described as a nucleolar protein that belongs to an evolutionary conserved protein family, which members are present in fungi, animal and plant kingdoms but are absent in bacteria. 24 The characteristic feature of the SURF6
proteins is the presence of a conservative domain positioned in the carboxyl terminus that has an average residue identity of 36% between different species and is enriched with lysine and arginine residues, which confer its overall basic charge (pI>10). 24 In mammals, SURF6 is a product of one of the six genes comprising the surfeit gene locus and is a typical housekeeping protein that is expressed in various tissues and throughout cell cycle in NIH/3T3 fibroblasts. 25, 26 A particularly high level of SURF6 expression has been described in actively proliferating cells, such as embryonic, progenitor and hematopoietic stem lineages. 27 Interestingly, in mouse spleenocytes activated for proliferation in vitro expression of SURF6 begins before that of the PCNA and Ki-67
proteins, which are the main proliferation markers in normal and cancer cells. 28 Presently, functions of SURF6 have mainly been studied in budding yeasts, where its homologue is named Rrp14/ykl082c. 29, 30 Rrp14p has been shown to play multiple roles in ribosome biogenesis, from synthesis of the primary 35S pre-rRNA transcript to assembly of the large and small ribosomal subunits. Additionally, knockout of Rrp14p retards the yeast proliferation by causing defects in budding and organization of the mitotic spindle. However, specific roles of SURF6 in proliferation and ribosome biogenesis in mammals await additional investigation. Based on large-scale cDNA transfection screening of colony formation, SURF6 has been identified as a putative cancer-related protein in cultured mouse fibroblasts and human cancer cells. 31 We have also shown that transient knockdown of SURF6 promotes death in mouse fibroblasts. 32 However, the degradation of rRNA known to occur in dead cells 33 did not allow us to examine a direct link between proliferation and ribosome production in SURF6-depleted cells.
In this study, in order to clarify the implication of SURF6 in proliferation and ribosome biogenesis, we establish a stable sub-line of mouse NIH/3T3 fibroblasts (called NIH/3T3-174 fibroblasts) which is capable to overexpress SURF6 in the presence of doxycycline. We show that upon appropriate doxycycline concentrations induction of SURF6 overexpression has no notable cytotoxicity but significantly accelerates proliferation unless the induced fibroblasts reach cell-cell contacts. Like its yeast homologue Rrp14, mammalian SURF6 is involved in rRNA processing along both ribosomal subunit maturation pathways. Overall, our data demonstrate that mammalian SURF6 is an rRNA processing factor, which promotes proliferation and accelerates G1/S transition in non-malignant fibroblasts. Our data endorse the hypothesis that mammalian SURF6 is a putative oncoprotein.
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Results
Phenotype of stably transfected NIH/3T3-174 fibroblasts
In order to determine the effect of the protein SURF-6 on the proliferation and ribosome biogenesis in mammalian cells, we establish a stable sub-line of mouse NIH/3T3
fibroblasts (called NIH/3T3-174 fibroblasts), which are capable to overexpress SURF6 in the presence of doxycycline. In Fig. 1a , the plasmid construct used to obtain stably transfected NIH/3T3-174 fibroblasts is shown. On Western blots of control (-Dox) and induced (+Dox) cells SURF6 is visible as a major band with an apparent molecular mass of 43 kDa that corresponds to the electrophoretic mobility of mouse SURF protein 25 ( Fig. 1b) . After 24 hours of 100 ng/ml doxycycline administration, the amount of SURF6 becomes about three times and after 48 hours -up to10 times higher than in In Fig. 1c-f , representative microscopic images of NIH/3T3-174 fibroblasts incubated without (-Dox) or with (+Dox) 100 ng/ml doxycycline for 48 hours are
shown. The control (-Dox) fibroblasts (Fig. 1c, d ) are almost EGFP-negative (Fig. 1c) , whereas the majority of +Dox cells (Fig. 1e , f) are brightly fluorescent (Fig. 1e) . Like in non-transfected cells, 25, 26 in +Dox NIH/3T3-174 fibroblasts, SURF6 distributes mainly within nucleoli (Fig. 1g) . It is worth mentioning that in cells with a stronger EGFP fluorescence, nucleoli are more intensely stained for SURF6 than the nucleoli in weakly EGFP-fluorescent cells (Fig. 1g , h, asterisks). There were no visible changes in largescale chromatin configuration upon SURF6 overexpression (Fig. 1i) . We also did not observe significant difference in the number of dead cells in -Dox and +Dox cell populations neither by conventional microscopy ( Fig. 1f) nor by the trypan blue excision test (Fig. 3j) . These data support a conclusion that excess of SURF6 does not cause significant cytotoxic effects at least within 24-48 hours of the induction.
Effects of SURF6 overexpression on cell proliferation
First, we examined effects of the SURF6 excess on cell proliferation in real time using the xCELLigence (RTCA)-DP system. Experiments were repeated several times, and the results of a representative one are shown Fig. 2a, b . The proliferation rate of NIH/3T3-174 fibroblasts was monitored in the presence of 10 ng/ml, 100 ng/ml or 1000 ng/ml doxycycline simultaneously with that of non-induced (-Dox) cells (Fig. 2a) . In . Both images demonstrate that 1000 ng/ml doxycycline appeared to suppress an increase of the cell number. On the contrary, 10 ng/ml and 100 ng/ml doxycycline start to promote cell proliferation shortly (~5-6 hrs) after the induction. The stimulating effects were intensified with time so that after 24-30 hours of the treatment the differences between the normalized cell indexes in the induced and control cells became significant (p<0.05; Fig. 2a, b) . Therefore, we concluded that induction of SURF6 overexpression observed in the presence of both doxycycline concentrations (i.e., 10 ng/ml and 100 ng/ml) confers fibroblasts with a proliferative advantage. Taking into account that doxycycline can be instable in neutral aqueous solutions, including culture medium, the antibiotic concentration of 100 ng/ml was used in all further experiments.
We then examined the proliferation rate of +Dox and -Dox NIH/3T3-174 fibroblasts by monitoring their number over time with conventional phase contrast microscopy and the MTT assay. For the microscopy, fibroblasts were seeded in Petri dishes, and cultured for 3 hours to ensure cell attachment to substrate (the T0 timepoint; Fig. 3a ). Twenty-five randomly selected fields of view were photographed shortly after and then after 24 and 48 hours cell culturing in the absence (Fig. 3b, d , -Dox) or the presence (Fig. 3c, (Fig. 3g, h ). Thus, three independent approaches, namely the xCELLigence analysis of cells in real time, conventional microscopy and the MTT assay showed that incubation of NIH/3T3-174 fibroblasts with 100 ng/ml doxycycline stimulated cell proliferation, and that this effect was particularly prominent after ~24
hours of the induction of SURF6 overexpression.
Calculation of the population doubling time
Taking into account the data mentioned above, we calculated the population doubling time at 24 and 48 hours of post-induction as described in Materials and Methods (see the formula No1). The results are summarized in Table 1 According to the t-test, in these cells the differences in population doubling time was not significant (p>0.05). We concluded therefore that in our cell system expression of Table 2 ).
We also noticed that overexpression of SURF6 increased the mitotic index from 4.4±0.4% in -Dox cells to 5.7±1.3% in +Dox cells, but these values did not differ significantly (p>0.05).
Putative mechanisms of SURF6 pro-proliferative effects
Like in normal cells, 25, 26 in +Dox NIH/3T3-174 fibroblasts SURF6 is located in nucleoli (Fig. 1g ). Considering this, we decided to examine whether SURF6 pro-proliferating effects are linked to ribosome biogenesis. To reach the aim, RNA was isolated from fibroblasts cultured without or with 100 ng/ml doxycycline for 24 hours, and then analyzed by Northern blots with [ 
Discussion
SURF6 and cell proliferation
Presently, a loss-of-function (knockdown) approach is routinely used to examine a putative involvement of nucleolar proteins in cell cycle control. Based on this approach, 
.
Here, by using stably transfected NIH/3T3-174 fibroblasts capable of conditional overexpression of SURF6 and by several independent approaches, i.e. monitoring cell proliferation in real time with the xCELLigence system, flow cytometry, and conventional phase-contrast microscopy, we have found that overexpression of SURF6 can promote proliferation of normal mammalian cells. In sub-confluent NIH/3T3-174 fibroblasts, overexpression of SURF6 diminishes the population doubling time (by ~20%, p<0.001), the duration of cell division cycle (by ~25%, p<0.001), and specifically shortens G1 phase (by ~30%, p<0.05) as compared with the non-induced cells (Tables 1 and 2 ). Moreover, calculations of the duration of cell cycle phases showed that SURF6 is unlikely to control S phase rather to be involved in the G1/S transition (Table 2) . Thus, our results indicate that the nucleolar protein SURF6 plays a role in cell proliferation control as a positive regulator of G1/S transition in non-malignant cells.
Importantly, the SURF6 pro-proliferating effects could be manifested only upon certain experimental conditions. Specifically, 1000 ng/ml doxycycline, the dose recommended for the Tet-On system in mammalian cells, 41 appeared to be toxic in NIH/3T3-174 fibroblasts (Fig. 2a, b ). An optimal doxycycline concentration, 100 ng/ml, significantly activated proliferation in sub-confluent fibroblasts but became less effective, when the cells reached confluency. Thus, after 48 hours of the induction, when a monolayer became nearly complete (Fig. 3d, e) , the cell proliferation doubling-time in +Dox cells (26.6±1.5 hours) exceeds that in -Dox cells (21.9±1.9 hours) despite differences between the values are insignificant (p>0.05) ( Table 1 ). Taking into account that proliferation of mouse 3T3 fibroblasts is inhibited when they reach confluence 50 and that in HeLa cells SURF6 interacts with the specific RNA polymerase I cofactor UBF, 42 which is suppressed in steady-state fibroblasts, 43 one could assume that SURF6 proproliferation activity may be mediated by contact inhibition and recruits UBF.
SURF6 and ribosome biogenesis
The yeast homologue of SURF6, the Rrp14 protein, functions in ribosome biogenesis as a regulatory factor required for maturation of both ribosomal subunits. In addition, in
Rrp14p-depleted cells 35S pre-rRNA synthesis appeared to decline. 29, 30 However, ribosome biogenesis steps, which recruit SURF6 in mammalian cells, remain undefined.
Here we show that in mouse fibroblasts conditional overexpression of SURF6 affects various steps of rRNA processing. Based on the Northern blot data, SURF6
overexpression causes accumulation of 34S and 20S rRNAs (the precursors for 18S rRNA) and of 32S rRNA that is a precursor for 28S rRNA (Fig. 5b-e) . Nonetheless, we did not observe an accumulation of the longest common precursor for 5.8S and 28S
rRNAs, the 36S rRNA ( Fig. 5b-e ). Considering this, it is tempting to speculate that SURF6 is involved in the cleavage of 36S rRNA along the ITS2 spacer (Fig. 5d ).
Northern blots also showed that an excess of SURF6 causes an accumulation of 45S pre-rRNA ( Fig. 5b-e ) that is formed downstream from the 47S pre-rRNA precursor (Fig. 5d ). This may result either from retardation of 45S pre-rRNA processing or from activation of the 47S pre-rRNA synthesis. The later assumption sounds more probable because the number of amplicons corresponding to the shortly lived 5'ETS fragments determined by qRT-PCR points to a 1.5-fold increase of the 47S pre-rRNA copies in +Dox fibroblasts as compared with -Dox cells (Fig. 5f ). The increase of 18S, 5.8S and 28S rRNA amplicons also detected by qRT-PCR (Fig. 5f ) is consistent with the Northern blot data, evidencing in favor that SURF6 is involved in the maturation of both subunits at the point of rRNA processing. (Fig. 5b-e) . In addition, the accumulation of these amplicons may arise from an increasing level of the cytoplasmic rRNAs, which
were not specifically identified on the blots.
Overall, our work concludes that the nucleolar protein SURF6 is involved in the maturation of both ribosomal subunits at the point of rRNA processing. Undoubtedly, SURF6 can stimulate proliferation of sub-confluent NIH/3T3-174 fibroblasts by decreasing their population doubling-time, shortening the cell division cycle and by facilitating G1/S transition, and thereby serves as a positive regulator of proliferation in non-malignant mammalian cells. Our results endorse the assumptions that SURF6 could be a putative oncoprotein 31 and an appropriate candidate for anti-cancer therapy.
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Material and methods
Cells and DNA plasmid constructs
Mouse embryo NIH/3T3 fibroblasts were purchased from the Russian Collection of Cell vector (Invitrogen, USA). The second (executive) plasmid, named as pBI-mSURF6, was engineered using a commercial vector pBI-EGFP (Clontech Laboratories, Inc.).
The NheI/NheI 1.9 kb cDNA fragment, corresponding to the mouse SURF6 coding region, was cut off from the pBS-Surf6 clone 25 and re-cloned to the NheI cloning sites of the pBI-EGFP vector. The resulted pBI-mSURF6 plasmid contains a bi-directorial TRE (tetracycline-responsible element) activated by the rtTA expression product flanked by two minimal bi-directorial CMV promoters which govern co-expression of SURF6 and EGFP (Fig. 1a) .
Transfections were performed with the Lipofectamine2000 reagent (Invitrogen, USA). NIH/3T3 fibroblasts were transfected with the pcDNA3.1(-)rtTA plasmid, and the transfectants were selected by one-month culturing in the presence of 450 µg/ml G418. Selected clones were co-transfected with the plasmid pBI-mSURF6 (to generate NIH/3T3-174 fibroblasts) or with the pBI-EGFP vector (to generate NIH/3T3-GFP cells capable to express EGFP alone) mixed in the equal amounts with a linear DNA fragment containing the puromycin-resistance gene. The DNA fragment of the puromycin-resistance gene was excised from the plasmid pLoxPuro with BamHI. 46 The transfectants were cultured in complete DMEM supplemented with 200 µg/ml G418 and 1 µg/ml puromycin for another month. Clones resistant to the second selection were transferred to wells of a 96-well plate and allowed growing. Most healthy clones were named as NIH/3T3-174 and NIH/3T3-GFP fibroblasts and used in the study.
The stably transfected cells were cultured in DMEM medium containing 10%
Tet-On approved fetal bovine serum (FBS, Clontech Laboratories, Inc.), 4.5 g/l glucose, 2 mM L-glutamine, 1.5 g/l sodium bicarbonate, penicillin and streptomycin (100 units/ml each), 200 µg/ml G418 and 0.5 µg/ml puromycin at 37° C and in the atmosphere of 5% CO 2 /95%. Cells were plated with initial density of 3-5×10 3 cell/сm 2 unless indicated otherwise. Doxycycline chloride (Sigma-Aldrich, USA) was dissolved in DMEM to the final concentrations 10, 100 or 1000 ng/ml and added to sub-confluent cells cultured in complete growth medium for 3-24 hours prior the induction. In control experiments (-Dox, non-induced cells), the equal volume of DMEM alone was added.
The initial cell density was counted with an automated cell counter Cedex XS Analyzer (Roche, USA).
Immunoblotting and immunofluorescence
For immunoblots, 5×10 6 cells were lysed in 500 µl buffer containing 50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 10% glycerol, 0.5% Triton X-100 and a cocktail of protease inhibitors (Sigma-Aldrich) on ice. The total protein concentration in samples was determined with the Lowry-Peterson assay using a Protein Assay Kit (Sigma-Aldrich). 
Analysis of cell growth with the xCELLigence System
The xCELLigence Real-Time Cell Analysis (RTCA)-DP system (ACEA Biosciences, CAL, USA) was used to monitor cell growth in real time according to. 
MTT assay
NIH/3T3-174 fibroblasts were seeded in 24-well plates in complete growth medium for 3 hours to be recovered. Cells were rinsed three times with PBS and incubated in serum-free medium for 24 hours, and afterwards 100 ng/ml doxycycline in DMEM (+Dox cells) or the equal volume of DMEM (-Dox cells) were added as described. 48 The MTT assay was executed as recommended by the manufacture (Life Technologies, France) shortly after doxycycline administration ("0" time-point) and also 24 and 48 hours later. Absorbance was read at 540 nm with a Thermo Scientific Multiskan EX ELISA reader (Thermo Fisher Scientific, USA). Experiments were repeated in triplicate.
Calculation of the population doubling time
Cells were seeded in 6 cm Petri dishes and after culturing for 3-4 hours, 100 ng/ml doxycycline in DMEM or DMEM alone (-Dox control) were added (time-point "0", 
where t is an interval (in hours) between T0 and Tt, and N0 and Nt are the average cell number per microscopic field of view at the same time-points. 49 Experiments were repeated five times.
Flow cytometry
Cells were fixed with 70% ethanol for 15 min at 4 о С and stained with 50 µg/ml propidium iodide (Sigma-Aldrich) in PBS containing 0.5 mg/ml bovine pancreatic RNAase A (Sigma-Aldrich) for 1 h at 37 о С. Above 1×10 4 cells were analyzed in each sample using a flow cytometer Epics "Elite" (Beckman Coulter Inc., USA) equipped with an argon laser Cyonics (Uniphase, USA) and Multigraph software (Coulter, USA).
Experiments were repeated four times.
Timing of cell cycle and the cell cycle phases
The duration of the cell division cycle (T, hours) was calculated according to 49 with the equation (No2):
where t d -the average cell population doubling time, and y -the average percentage of
G0 cells (G0 index).
To determine the G0 index, cells were seeded on coverslips, cultured overnight and incubated with 10 mМ Br-dU (-Dox control cells) or 10 mМ Br-dU + 100 ng/ml doxycycline (+Dox cells) for 24 hours, a period that exceeds the division cycle in 3T3
fibroblasts. 50 The The length of G1 phase (t G1, hours) was calculated with the formula (No5)
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where T is the durations of cell division cycle, t S is the duration of S phase, and t G2+M is the sum duration of G 2 phase and mitosis determined according to the formula (3). 
Northern blot analysis
Approximately 1×10 6 cells were lysed with 1 ml TRIzol ® Reagent (Life Technologies, USA) and RNA was isolated as recommended by the manufacture and then quantified with a nanodrop spectrophotometer (Thermo-Scientific). In all samples, the ratio А260/А280 was within the range of 1.9 to 2.0 thus indicating the absence of protein impurities. RNA was processed for Northern blotting as described previously. 52 Five micrograms of total RNAs were fractionated on standard 1% agarose/6% formaldehyde gels to analyse RNA species. Fifty pmol of a probe was mixed with 50 pmol of [γ- 
Quantitative reverse transcription PCR (qRT-PCR)
Total RNA was isolated from -Dox and +Dox fibroblast after 24 hours of 100 ng/ml doxycycline administration and used to determine expression of rRNA species as described in. 53 The 
Statistical analysis
Results are expressed as mean ± standard error of the mean (SEM Induction of SURF6 overexpression with 10 ng/ml and 100 ng/ml doxycycline significantly (p<0.05) activates proliferation as compared with non-stimulated NIH/3T3-174 fibroblasts, whereas 1000 ng/ml doxycycline turns out to be cytotoxic for the cells. Table 2 . Duration (in hours) of cell cycle phases in sub-confluent NIH/3T3-174 fibroblasts cultured without (-Dox) or with (+Dox) 100 ng/ml doxycycline for 24 hours after seeding. In brackets, the formulae used for calculations are indicated (see Materials and Methods for detail).
The percentage of cells at G0/G1, S and G2/mitosis phases was determined by flow cytometry.
The percentage of G0 cells was measured by cell population culturing with Br-dU for 24 hours.
The Cell division cycle (2) 17.6±0.6 14.0±0.4
G1 phase (5) 34.6±1. 
